FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer

@article{Siggelkow2004FDGPA,
  title={FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer},
  author={Wulf Siggelkow and W. Rath and Udalrich B{\"u}ll and Michael Zimny},
  journal={European Journal of Nuclear Medicine and Molecular Imaging},
  year={2004},
  volume={31},
  pages={S118-S124}
}
Breast cancer continues to be one of the most common cancers in North America and Western Europe. Positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-d-glucose (FDG PET) represents a non-invasive functional imaging modality that is based on metabolic characteristics of malignant tumours. In breast cancer, FDG PET is more accurate than conventional methods for staging of distant metastases or local recurrences and enables early assessment of treatment response in patients undergoing… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Similar Papers

Loading similar papers…